Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2000

01-05-2000

Genetic hypoglycaemia in infancy and childhood: Pathophysiology and diagnosis

Authors: J. M. Saudubray, P. De Lonlay, G. Touati, D. Martin, M. C. Nassogne, P. Castelnau, C. Sevin, C. Laborde, C. Baussan, M. Brivet, A. Vassault, D. Rabier, J. P. Bonnefont, P. Kamoun

Published in: Journal of Inherited Metabolic Disease | Issue 3/2000

Login to get access
Metadata
Title
Genetic hypoglycaemia in infancy and childhood: Pathophysiology and diagnosis
Authors
J. M. Saudubray
P. De Lonlay
G. Touati
D. Martin
M. C. Nassogne
P. Castelnau
C. Sevin
C. Laborde
C. Baussan
M. Brivet
A. Vassault
D. Rabier
J. P. Bonnefont
P. Kamoun
Publication date
01-05-2000
Publisher
Kluwer Academic Publishers
Published in
Journal of Inherited Metabolic Disease / Issue 3/2000
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1023/A:1005675827612

Other articles of this Issue 3/2000

Journal of Inherited Metabolic Disease 3/2000 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine